Analytical Data
-
基因名
ST7L
- Application
-
别名
ST7L; ST7R; Suppressor of tumorigenicity 7 protein-like; ST7-related protein
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TDW4
-
表达区间
1-575 aa
-
氨基酸序列
MADRGGVGEAAAVGASPASVPGLNPTLGWRERLRAGLAGTGASLWFVAGLGLLYALRIPLRLCENLAAVTVFLNSLTPKFYVALTGTSSLISGLIFIFEWWYFHKHGTSFIEQVSVSHLQPLMGGTESSISEPGSPSRNRENETSRQNLSECKVWRNPLNLFRGAEYRRYTWVTGKEPLTYYDMNLSAQDHQTFFTCDTDFLRPSDTVMQKAWRERNPPARIKAAYQALELNNDCATAYVLLAEEEATTIVDAERLFKQALKAGETIYRQSQQCQHQSPQHEAQLRRDTNVLVYIKRRLAMCARKLGRIREAVKIMRDLMKEFPPLTMLNIHENLLESLLELQAYPDVQAVLAKYDDISLPKSAAICYTAALLKTRTVSEKFSPETASRRGLSTAEINAVEAIHRAVEFNPHVPKYLLEMKSLILPPEHILKRGDSEAIAYAFFHLQHWKRIEGALNLLQCTWEGTFRMIPYPLEKGHLFYPYPSCTETADRELLPTFHHVSVYPKKELPLFIHFTAGFCSSTAMIAILTHQFPEIMGIFAKAVLGLWCPQPWASSGFEENTQDLKSEDLGLSSG
-
分子量
91.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ST7L is a member of the suppressor of tumorigenicity 7 (ST7) family, which has garnered attention in cancer research due to its potential role as a tumor suppressor. Studies have indicated that ST7L could be involved in various cellular processes, including cell proliferation, apoptosis, and differentiation. The expression levels of ST7L have been found to be downregulated in several cancer types, suggesting its involvement in tumorigenesis. Research has focused on the characterization of ST7L at the molecular level, aiming to understand its structure and function, and how it interacts with other proteins and signaling pathways. Recombination technologies have been utilized to produce ST7L recombinant proteins, facilitating a deeper investigation into their biological properties and potential as therapeutic agents. Additionally, understanding the mechanisms by which ST7L regulates various cellular pathways may offer insights into novel cancer treatment strategies. Current studies are exploring the implications of ST7L in tumor microenvironments and its potential role in immune response, highlighting its importance in the development of targeted therapies. As ongoing research continues to elucidate the precise functions and mechanisms of ST7L, its significance in cancer biology and therapy remains a vibrant area of investigation.
